Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant
- 31 August 2009
- journal article
- Published by Elsevier in Human Immunology
- Vol. 70 (8) , 580-583
- https://doi.org/10.1016/j.humimm.2009.04.011
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Donor-Directed HLA Antibodies Before and After Transplantectomy Detected by the Luminex Single Antigen AssayTransplantation, 2009
- Excellent Renal Allograft Survival in Donor-Specific Antibody Positive Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte GlobulinTransplantation, 2009
- Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific AntibodiesClinical Journal of the American Society of Nephrology, 2008
- Pretransplant Donor-Specific Antibodies in Cytotoxic Negative Crossmatch Kidney Transplants: Are They Relevant?Transplantation, 2008
- Luminex donor‐specific crossmatchesTissue Antigens, 2008
- Clinical Relevance of Preformed HLA Donor-Specific Antibodies in Kidney TransplantationAmerican Journal of Transplantation, 2008
- Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry CrossmatchesAmerican Journal of Transplantation, 2007
- The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant PatientsAmerican Journal of Transplantation, 2007
- Humoral Theory of Transplantation: Mechanism, Prevention, and TreatmentHuman Immunology, 2005
- Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class IHuman Immunology, 2004